Zhejiang Jiuzhou Pharmaceutical Co., Ltd is engaged in the research, development, production, and sale of specialty active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and custom development and manufacturing organization (CDMO) services.
## Business Segments
The company operates through Specialty APIs and Intermediates, Patented APIs and Intermediates, and Other Related Products and Services segments.
### Specialty APIs and Intermediates
This segment includes the researc...
Zhejiang Jiuzhou Pharmaceutical Co., Ltd is engaged in the research, development, production, and sale of specialty active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and custom development and manufacturing organization (CDMO) services.
## Business Segments
The company operates through
Specialty APIs and Intermediates
,
Patented APIs and Intermediates
, and
Other Related Products and Services
segments.
### Specialty APIs and Intermediates
This segment includes the research, development, production, and sale of specialty active pharmaceutical ingredients and intermediates. These are chemical compounds that are essential for the synthesis of finished pharmaceutical products. The company's specialty APIs and intermediates are widely used in drug manufacturing for various therapeutic areas such as oncology, cardiovascular, anti-infective, and central nervous system disorders.
### Patented APIs and Intermediates
This segment focuses on developing and producing APIs and intermediates protected by patents or used in the production of patented drugs. The company's patented API and intermediate business supports the pharmaceutical industry's demand for innovative and high-value compounds, especially in new drug development and commercialization.
### Other Related Products and Services
This segment offers various products and services, including custom chemical synthesis, process development, and contract manufacturing for pharmaceutical and biotechnology clients.
## Business Strategy
The company follows a business strategy centered on technological innovation, customer-centricity, and sustainable development. Continuous investment in research and development is emphasized to drive innovation in chemical synthesis, process engineering, and green chemistry. Research and development efforts focus on developing new synthetic routes, enhancing process efficiency, and reducing environmental impact.
Customer-centricity is a crucial aspect of the company's strategy. The business model aims to provide tailored solutions, flexible manufacturing capacity, and responsive technical support to pharmaceutical clients. Long-term partnerships with global clients are based on trust, technical expertise, and reliable supply. Delivering high-quality products and services tailored to clients' specific needs has established the company as a preferred partner for pharmaceutical innovation and supply chain management.
Sustainable development is another key element of the company's strategy. The company is dedicated to environmental protection, occupational health, and safety, with a comprehensive EHS management system based on international best practices.
## Products and Services
The company offers a wide range of products and services in the pharmaceutical industry, focusing on specialty APIs, pharmaceutical intermediates, and CDMO services.
-
Specialty APIs and Intermediates
: Essential chemical compounds for the synthesis of finished pharmaceutical products, used in various therapeutic areas.
-
Patented APIs and Intermediates
: Development and production of APIs and intermediates protected by patents or used in patented drug manufacturing.
-
CDMO Services
: Custom synthesis, process development, and contract manufacturing services for innovative pharmaceutical products.
-
Custom Chemical Synthesis and Process Development
: Custom chemical synthesis and process development services for pharmaceutical and biotechnology clients.
## Geographical Markets
The company serves a global customer base, supplying products and services to pharmaceutical companies in major international markets such as the United States, Europe, and Japan. Business operations are primarily located in China.
## Customers
The customer base includes multinational pharmaceutical companies, generic drug manufacturers, and biotechnology firms. Long-term partnerships with global clients are based on trust, technical expertise, and reliable supply.
## Sales and Marketing
The business model focuses on customer-centricity, customized solutions, and responsive technical support, indicating a direct engagement approach with pharmaceutical clients and long-term partnership development.
## Government Regulations
The company complies with international quality standards and regulatory requirements, including Good Manufacturing Practice (GMP) guidelines, to ensure product safety, efficacy, and reliability.
The governance structure ensures compliance with relevant laws, administrative regulations, and the requirements of the China Securities Regulatory Commission regarding the governance of listed companies.
## History
Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973.
Das Analystenkursziel zeigt auf einen Blick die Mindest-, Höchst- und Durchschnittserwartung der Analysten.
